Hermansky-Pudlak syndrome (HPS). An epidemiologic study

Area of Science:

• Genetics
• Ophthalmology
• Hematology

Background:

• Albinism presents with various genetic causes.
• Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder characterized by oculocutaneous albinism and a bleeding tendency.
• Previous research has not fully elucidated the prevalence and specific characteristics of HPS in diverse populations.

Purpose of the Study:

• To determine the prevalence and phenotypic characteristics of albinism in Puerto Rico.
• To identify the proportion of albinism cases attributed to Hermansky-Pudlak syndrome (HPS).
• To investigate the genetic basis and diagnostic markers for HPS within the studied population.

Main Methods:

• Population-based study identifying individuals with albinism in Puerto Rico.
• Clinical assessment and genetic analysis to determine the type of albinism.
• Electron microscopy to examine platelet dense bodies for HPS diagnosis.

Main Results:

• 693 individuals with albinism were identified; 595 had their type determined.
• Hermansky-Pudlak syndrome (HPS) accounted for 495 of these cases, representing approximately five out of six individuals with albinism.
• The highest HPS prevalence was in northwestern Puerto Rico (1 in 1,800), with a carrier frequency of 1 in 21. Phenotypic variability in pigmentation and ceroid storage was observed, but platelet storage pool deficiency was consistent.
• Diagnosis of HPS was confirmed by the absence of platelet dense bodies via electron microscopy.

Conclusions:

• Hermansky-Pudlak syndrome (HPS) is highly prevalent in the Puerto Rican population, particularly in the northwestern region.
• HPS exhibits variable phenotypic expression but is consistently associated with platelet dense body deficiency.
• Family studies suggest HPS is a distinct genetic disorder resulting from single gene mutations or small deletions.